secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2026-10-14T20:30:12+00:00
Accession:  0001213900-26-109457
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Silo Pharma acquires 'Reputation Endpoints' software from Larry King for 150,000 shares
--------------------------------------------------------------------------------

- Asset purchase agreement dated Oct 13, 2026: Silo Pharma buys the source and object code for web-based tools marketed as 'Reputation Endpoints' plus all related IP.
- Purchase price is 150,000 shares of common stock ($0.0001 par), delivered within five business days; Seller delivers the software within three days of receipt.
- Shares are locked up for 12 months, ending earlier upon a Change in Control or the Company's written consent.
- Larry King indemnifies for misrepresentation, third-party infringement, gross negligence or fraud; liability capped at the fair market value of the 150,000 shares; reps survive 12 months.
- Seller warrants the software is original, free of malicious code, has no undisclosed open-source components, and that he is exclusive owner free of liens or prior licenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026109457/0001213900-26-109457-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026109457/ea0308562-8k_silo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-109457

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer